ISO 10993-3:2026
ISO 10993-3:2026

ISO 10993-3:2026

August 2026
International standard Current

Biological evaluation of medical devices — Part 3: Evaluation of genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity

This document specifies strategies for risk estimation and evaluation of biological harms with respect to:genotoxicity;carcinogenicity;reproductive toxicity; anddevelopmental toxicity.This document is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity has been established. This document is not applicable to active pharmaceutical ingredients of device-drug combination products or biological components of device-biologic combination products which are covered by regulations.NOTE            Guidance on selecting relevant biological effects for medical devices is covered in ISO 10993-1.

View the extract
Main informations

Collections

International ISO standards

Publication date

August 2026

Number of pages

41 p.

Reference

ISO 10993-3:2026

ICS Codes

11.100.20   Biological evaluation of medical devices

Print number

4
Sumary
Biological evaluation of medical devices — Part 3: Evaluation of genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity

This document specifies strategies for risk estimation and evaluation of biological harms with respect to:

  • genotoxicity;
  • carcinogenicity;
  • reproductive toxicity; and
  • developmental toxicity.

This document is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity has been established.

This document is not applicable to active pharmaceutical ingredients of device-drug combination products or biological components of device-biologic combination products which are covered by regulations.

NOTE            Guidance on selecting relevant biological effects for medical devices is covered in ISO 10993-1.

Replaced standards (2)
ISO/TR 10993-33:2015
ISO/TR 10993-33:2015
March 2015
Technical report Current
Biological evaluation of medical devices - Part 33 : Guidance on tests to evaluate genotoxicity - Supplement to ISO 10993-3

There are differences between the views of regulatory bodies on the subject of genotoxicity testing. The purpose of this ISO/TR 10993-33: 2015 is to provide background information to facilitate the selection of tests and guidance on the performance of tests.

ISO 10993-3:2014
ISO 10993-3:2014
September 2014
International standard Current
Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity

ISO 10993-3:2014 specifies strategies for risk estimation, selection of hazard identification tests and risk management, with respect to the possibility of the following potentially irreversible biological effects arising as a result of exposure to medical devices: genotoxicity; carcinogenicity; reproductive and developmental toxicity. ISO 10993-3:2014 is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, or reproductive toxicity has been established.

ZOOM ON ... the Requirements department

To comply with a standard, you need to quickly understand its issues in order to determine its impact on your activity.

The Requirements department helps you quickly locate within the normative text:

  • mandatory clauses to satisfy,
  • non-essential but useful clauses to know, such as permissions and recommendations.

The identification of these types of clauses is based on the document "ISO/IEC Directives, Part 2 - Principles and rules of structure and drafting of ISO documents" as well as on a constantly enriched list of verbal forms.

With Requirements, quickly access the main part of the normative text!


Need to identify, monitor and decipher standards?